Loading...

NAYA Biosciences, Inc. Common Stock

IVFNASDAQ
Healthcare
Medical - Healthcare Plans
$2.24
$0.05(2.28%)

NAYA Biosciences, Inc. Common Stock (IVF) Company Profile & Overview

Explore NAYA Biosciences, Inc. Common Stock’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NAYA Biosciences, Inc. Common Stock (IVF) Company Profile & Overview

INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care. The company focuses on building, acquiring, and operating fertility clinics, including “INVO Centers” offering the intravaginal culture (IVC) procedure enabled by its proprietary INVOcell® medical device. This device allows fertilization and early embryo development to occur in vivo within the woman’s body, providing a more natural, intimate, and affordable alternative to traditional IVF. INVO Fertility operates multiple centers in the U.S. and distributes the INVOcell technology to third-party clinics. The company separated its fertility and oncology businesses in April 2025 to focus exclusively on fertility care.

SectorHealthcare
IndustryMedical - Healthcare Plans
CEOSteven M. Shum

Contact Information

1 978-878-9505
5582 Broadcast Court, Sarasota, FL, 34240

Company Facts

33 Employees
IPO DateJan 14, 2025
CountryUS
Actively Trading

Frequently Asked Questions

;